From: Becker's Spine Review <>
Subject: New spine technology purchase-7 key factors for surgeons | Merrill Lynch's top 8 healthcare stocks | Amedica, K2M, VertiFlex & more-13 key notes | Webinar: False Claims Issues & Claims-10 Key Points for Hospitals & ASCs
Tex View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+
Dec. 22, 2014
Today's Top Stories
1. To buy or not to buy? 7 key factors in choosing new spine technology Full story    
2. Top 8 healthcare stocks from Merrill Lynch Full story

3. Amedica, K2M, VertiFlex & more - 13 key notes Full story

4. Webinar: False Claims Issues and Claims - 10 key points for hospitals and ASCs. To learn more and register, click here.

5. Scoliosis Research Society names 8 board members for 2014-2015 Full story

6. 34 orthopedic, spine devices receive FDA 510(k) clearance in November 
Full story 


7. How will the Republican sweep of the House and Senate affect the spine industry? If you'd like to contribute to this article, contact Anuja Vaidya at by Dec. 24.

8. 8 key thoughts on Stryker's place in the orthopedic device market Full story 


9. The value of lab data in the healthcare ecosystem Full story

10. The 5 states most prepared for infection disease outbreaks Full story

11. 13 biggest healthcare stories this week Full story  


Contact Us

Editorial Contact: 
Laura Dyrda
(800) 417-2035
email editorial

Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Spine Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Forward this email

This email was sent to by |  

Becker's Spine Review | 35 E. Wacker Dr. #1782 | Chicago | IL | 60601